InnoCan Pharma Corp.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -13.39% vs 47.37% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -33.33% vs -200.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.70",
          "val2": "11.20",
          "chgp": "-13.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.60",
          "val2": "0.70",
          "chgp": "-14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.60",
          "val2": "-0.70",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.40",
          "val2": "-0.30",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "56.50%",
          "val2": "62.70%",
          "chgp": "-0.62%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 119.02% vs 457.58% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 92.98% vs -11.76% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.30",
          "val2": "18.40",
          "chgp": "119.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.70",
          "val2": "-5.10",
          "chgp": "66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.00",
          "val2": "-0.30",
          "chgp": "1,100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.40",
          "val2": "-5.70",
          "chgp": "92.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-42.40%",
          "val2": "-278.50%",
          "chgp": "23.61%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

9.70

11.20

-13.39%

Operating Profit (PBDIT) excl Other Income

0.60

0.70

-14.29%

Interest

0.00

0.00

Exceptional Items

-0.60

-0.70

14.29%

Consolidate Net Profit

-0.40

-0.30

-33.33%

Operating Profit Margin (Excl OI)

56.50%

62.70%

-0.62%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -13.39% vs 47.37% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -33.33% vs -200.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

40.30

18.40

119.02%

Operating Profit (PBDIT) excl Other Income

-1.70

-5.10

66.67%

Interest

0.00

0.00

Exceptional Items

3.00

-0.30

1,100.00%

Consolidate Net Profit

-0.40

-5.70

92.98%

Operating Profit Margin (Excl OI)

-42.40%

-278.50%

23.61%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 119.02% vs 457.58% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 92.98% vs -11.76% in Dec 2023

All Annual Results